[{"AccountsPayableCurrent_0_Q1_USD":21174000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":40790000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-9532000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-19679000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":-34429000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":28605000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":486195000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q1_USD":34053000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":817109000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":851162000.0,"OtherAssetsCurrent_0_Q1_USD":122468000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":16437000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-2565000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-1954000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.35,"StockRepurchasedDuringPeriodShares_1_Q1_shares":1500000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-48304000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-3437000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":309614000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-61737000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-10254000.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q1_USD":90550000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-50171000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-60425000.0,"AmortizationOfFinancingCosts_1_Q1_USD":595000.0,"LongTermLoansFromBank_0_Q1_USD":59930000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-1062000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":133367000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":459352000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":7652000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":544375000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":11603000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":9000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-1954000.0,"NumberOfReportableSegments_1_Q1_Segment":2.0,"NumberOfOperatingSegments_1_Q1_Segment":2.0,"MinorityInterestPeriodIncreaseDecrease_1_Q1_USD":-10254000.0,"InvestmentIncomeNet_1_Q1_USD":10479000.0,"IncreaseDecreaseInOtherEmployeeRelatedLiabilities_1_Q1_USD":-20920000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":28000000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":467842000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":120811000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-197092000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q1_Investment":320.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1897892000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":4829000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":4840000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":11000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":40790000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":11603000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2233644000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":139429000.0,"OtherAssetsNoncurrent_0_Q1_USD":32552000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-10254000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":163952000.0,"ProfitLoss_1_Q1_USD":-58480000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":9080000.0,"NetIncomeLoss_1_Q1_USD":-48226000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-7584000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-95007000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-94501000.0,"LiabilitiesCurrent_0_Q1_USD":258025000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":3090913000.0,"Liabilities_0_Q1_USD":1520502000.0,"InventoryNet_0_Q1_USD":22885000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":411000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-3257000.0,"Depreciation_1_Q1_USD":3233000.0,"CostsAndExpenses_1_Q1_USD":194494000.0,"CommonStockValue_0_Q1_USD":139000.0,"CommonStockSharesOutstanding_0_Q1_shares":139282168.0,"CommonStockSharesIssued_0_Q1_shares":139282168.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":486195000.0,"AssetsCurrent_0_Q1_USD":2558045000.0,"Assets_0_Q1_USD":3090913000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-27235000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":32946000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-846309000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"StockholdersEquity_0_Q1_USD":1360239000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"MinorityInterest_0_Q1_USD":210172000.0,"EarningsPerShareBasic_1_Q1_USD":-0.35,"CostOfGoodsAndServicesSold_1_Q1_USD":2548000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":1570411000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-99000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":26750000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":8834000.0,"InventoryWorkInProcess_0_Q1_USD":2645000.0,"InventoryRawMaterials_0_Q1_USD":19638000.0,"InventoryFinishedGoods_0_Q1_USD":602000.0,"IncreaseDecreaseInInventories_1_Q1_USD":2181000.0,"IncomeTaxesPaid_1_Q1_USD":3000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.0528,"AmortizationOfIntangibleAssets_1_Q1_USD":486000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":139429000.0,"ShareBasedCompensation_1_Q1_USD":40790000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":74994000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":90550000.0,"OperatingIncomeLoss_1_Q1_USD":-61127000.0,"InterestPaidNet_1_Q1_USD":601000.0,"InterestExpense_1_Q1_USD":10990000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":62507000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q1_USD":7652000.0,"Ticker":"IONS","CIK":"874015","name":"IONIS PHARMACEUTICALS INC","OfficialName":"Ionis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5803570258.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]